Biofrontera AG: Biofrontera AG announces revised strategy

Leverkusen, Germany (pta018/20.02.2024/13:45 UTC+1)

Biofrontera AG today entered into an agreement with Biofrontera Inc. to modify the business relationship between the two companies. Biofrontera AG will focus on capitalizing its existing projects and know-how, while research and development will no longer be a core part of its activities. This revised strategy and the amended agreement with Biofrontera AG's largest customer, Biofrontera Inc., will have a significant impact on the structure of revenues and costs, both of which will be reduced. Biofrontera AG will provide new guidance for 2024 in due course.

(end)

Emitter:	Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany
Contact Person:	Investor Relations
Phone:	+49 (0) 214 87 63 20
E-Mail:	ir@biofrontera.com
Website:	www.biofrontera.com
ISIN(s):	DE0006046113 (Share)
Stock Exchange(s):	Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate